Complete Blood Count (CBC) with Differential
The Complete Blood Count with Differential quantifies and characterises white blood cells (5-part leucocyte differential with absolute counts), red blood cells (with haemoglobin, haematocrit, and erythrocyte indices including MCV, MCH, MCHC, and RDW), and platelets (with mean platelet volume) from a single EDTA whole blood specimen.
3
Biomarkers
Blood (whole blood)
Sample
1–2 business days
Turnaround
No — fasting is not required for the CBC and has no clinically meaningful effect on haematological parameters. The pre-analytical handling protocol below is substantially more critical to result accuracy than fasting status for this specimen type.
Fasting
What is the CBC with Differential test?
The Complete Blood Count with Differential is the most frequently ordered laboratory test in clinical medicine and the foundational haematological screen in every setting from acute hospital care to preventive health assessment. A single EDTA whole blood specimen collected by phlebotomy provides simultaneous quantification and characterisation of all three major blood cell lineages — the leucocyte count with 5-part differential characterising immune system status and inflammatory response; the erythrocyte count with indices and haemoglobin characterising oxygen transport capacity and anaemia type; and the platelet count with MPV characterising haemostatic capacity — in a panel whose individual components interact diagnostically and whose combined picture is substantially more informative than any single marker in isolation. The CBC serves three broad clinical roles. As a diagnostic tool, it identifies pathological states across haematological disease, infection, inflammation, nutritional deficiency, bone marrow pathology, and haemostatic disorders. As a safety baseline, it is the mandatory pre-treatment screen before initiating medications with haematological adverse effect profiles — chemotherapy, immunosuppressants, anticoagulants, clozapine, carbimazole, methotrexate, and many others — establishing a starting point for serial monitoring. As a monitoring tool, it tracks disease progression, treatment response, and medication toxicity over time with objective, quantitative haematological data. The interpretation of a CBC is not complete without clinical context — the same CBC values carry different implications in a 25-year-old female athlete, a 70-year-old patient on chemotherapy, and a 45-year-old presenting acutely unwell with fever, and the CBC should always be read in the clinical context documented on the requisition form.
What does the CBC with Differential test measure?
Leucocytes are produced in the bone marrow from haematopoietic stem cells under cytokine and colony-stimulating factor regulation and circulate in two pools: a freely circulating pool (measured by venepuncture) and a marginated pool adhered to vascular endothelium (released by catecholamines and acute physiological stress, producing the 'demargination leucocytosis' of exercise and acute anxiety). The 5-part automated differential classifies leucocytes by size and granularity using light scatter and impedance technology, providing proportional and absolute counts for each subtype. Neutrophils are the dominant innate immune phagocytes mobilised within hours of bacterial infection; lymphocytes encompass T-cells, B-cells, and NK-cells mediating adaptive and cytotoxic immunity; monocytes are the precursors to tissue macrophages and dendritic cells; eosinophils mediate allergic and anti-parasitic responses; and basophils participate in IgE-mediated hypersensitivity. The neutrophil-to-lymphocyte ratio (NLR) — a derived value from the differential — is an emerging systemic inflammatory marker with validated prognostic significance across cardiovascular disease, infectious illness, and oncological outcomes.
The WBC count and 5-part differential is the primary haematological screen for infectious, inflammatory, allergic, and haematoproliferative conditions. Neutrophilia with a left shift (circulating band cells on manual film review) indicates acute bacterial infection, tissue necrosis, or physiological stress response. Lymphocytosis with reactive lymphocytes indicates viral infection — EBV and CMV being the most clinically significant — or lymphoproliferative disease in older patients. Eosinophilia directs investigation toward atopic disease, parasitic infection, drug hypersensitivity, or eosinophilic organ infiltration. Unexplained neutropenia (ANC <1.8 ×10³/µL) requires urgent assessment. In integrated panel interpretation, the differential provides the inflammatory and immune context for all other CBC findings.
Erythrocytes are biconcave, anucleate discs produced by bone marrow erythropoiesis under erythropoietin (EPO) stimulation, with a circulating lifespan of approximately 120 days. Each contains approximately 270 million haemoglobin tetramers — the iron-containing oxygen transport protein — constituting the cell's primary function of oxygen delivery and carbon dioxide removal. Erythrocyte indices are computed by automated haematology analysers from primary count and haemoglobin measurements: MCV (mean corpuscular volume) classifies erythrocyte size; MCH (mean corpuscular haemoglobin) quantifies per-cell haemoglobin content; MCHC (mean corpuscular haemoglobin concentration) reflects haemoglobin density within cells; and RDW (red cell distribution width) quantifies size heterogeneity — anisocytosis — which rises early in developing nutritional deficiencies before MCV changes. Reticulocytosis and polychromasia on film reflect accelerated bone marrow output, detectable by automated analysers as elevated immature reticulocyte fraction.
The erythrocyte parameters are the primary screening data for anaemia, erythrocytosis, and morphological classification of haematological disease. Haemoglobin below the sex-specific lower limit confirms anaemia; MCV-based classification directs the diagnostic pathway — microcytic (MCV <80 fL: iron deficiency, thalassaemia, sideroblastic, anaemia of chronic disease), normocytic (MCV 80–100 fL: haemolysis, chronic disease, early mixed deficiency, bone marrow suppression), or macrocytic (MCV >100 fL: B12 or folate deficiency, liver disease, hypothyroidism, medication effect). RDW elevation is the earliest haematological indicator of iron, B12, or folate deficiency — preceding MCV change by weeks — and high RDW in a normocytic anaemia strongly suggests a mixed or evolving nutritional deficiency. Haemoglobin is the single most clinically ordered parameter in the CBC and drives urgent management decisions at both extremes.
Platelets are anucleate cytoplasmic fragments shed from megakaryocytes in the bone marrow under thrombopoietin (TPO) regulation, with a circulating lifespan of 8–12 days. They mediate primary haemostasis through adhesion to exposed subendothelial collagen via the GPIb-IX-V/von Willebrand factor axis, activation with release of granule contents (ADP, thromboxane A2, serotonin, platelet factor 4), and aggregation forming the primary platelet plug that precedes coagulation cascade amplification. Mean platelet volume (MPV) reflects the average platelet size — larger platelets are metabolically more active, contain more granules, generate more thromboxane A2, and have higher surface glycoprotein density, conferring greater thrombogenic potential per platelet than smaller variants.
Platelet count quantification is essential across haematology, haematostasis, and pharmacological safety monitoring. Thrombocytopenia (<150 ×10³/µL) may indicate immune thrombocytopenic purpura, drug-induced thrombocytopenia, bone marrow failure, splenic sequestration, or consumptive coagulopathy (DIC, TTP, HUS) — each requiring distinct management. Thrombocytosis (>400 ×10³/µL) most commonly reflects reactive thrombocytosis from iron deficiency, infection, or post-splenectomy state, with essential thrombocythaemia a consideration when reactive causes are excluded and counts persistently exceed 600–800 ×10³/µL. MPV carries emerging cardiovascular prognostic significance — elevated MPV has been associated with increased platelet reactivity and higher risk of arterial thrombotic events including myocardial infarction.
Why is the CBC with Differential test ordered?
- Routine preventive health screening — annual or biennial CBC as part of comprehensive health monitoring in adults to establish a longitudinal haematological baseline and detect early haematological abnormalities before symptoms emerge
- Symptomatic presentation workup — unexplained fatigue, dyspnoea on exertion, pallor, palpitations, unexplained weight loss, fever, lymphadenopathy, easy bruising or bleeding, petechiae, or night sweats where haematological pathology is a plausible differential requiring systematic exclusion
- Pre-medication safety baseline — CBC before initiating chemotherapy, methotrexate, azathioprine, clozapine, carbimazole, hydroxyurea, antiretrovirals, anticoagulants, and any pharmacological agent with known bone marrow, leucocyte, erythrocyte, or platelet adverse effects
- Infection and inflammatory disease evaluation — WBC count and differential to characterise the infectious or inflammatory aetiology (bacterial vs viral vs allergic vs haematoproliferative) and assess severity and systemic response
- Anaemia investigation — as the first-tier haematological test establishing haemoglobin severity and MCV-based morphological classification, directing the targeted second-tier investigation (iron panel, B12, folate, reticulocyte count, haemoglobin electrophoresis) appropriate to the morphological class
- Thrombocytopenia and bleeding tendency assessment — platelet count quantification in patients with unexplained bruising, petechiae, prolonged bleeding, or incidentally noted low platelet count, with urgency determined by count severity and concurrent bleeding symptoms
- Chronic disease monitoring — serial CBC in patients with known haematological malignancy, chronic kidney disease (anaemia of CKD monitoring), inflammatory bowel disease (anaemia and leucocyte monitoring), HIV (CD4 surrogate assessment and ART toxicity monitoring), and autoimmune disease (cytopenia screening)
- Integrative and functional medicine baseline assessment — CBC as the foundational haematological component of any comprehensive new-patient workup, providing the erythrocyte, leucocyte, and platelet picture required to contextualise all nutritional, hormonal, and metabolic findings in the broader health assessment
Sample collection and turnaround
Sample type
Blood (whole blood)
Fasting required
No — fasting is not required for the CBC and has no clinically meaningful effect on haematological parameters. The pre-analytical handling protocol below is substantially more critical to result accuracy than fasting status for this specimen type.
Collection method
Venipuncture at patient service centre
Turnaround
1–2 business days
Collection notes
Collect into EDTA anticoagulant tube (lavender / purple top). Immediately after needle withdrawal, gently invert the tube 8–10 times — this is the single most important collection step for CBC accuracy; thorough EDTA mixing prevents microclot formation and EDTA-dependent pseudothrombocytopenia. Do not shake the tube. Do not refrigerate the specimen. Transport to Access Medical Laboratories within 6–8 hours of collection at ambient temperature (18–25°C). Document on the requisition form: (1) current medications with haematological effects — chemotherapy, methotrexate, immunosuppressants, anticoagulants, clozapine, carbimazole, hydroxyurea, antiretrovirals; (2) acute symptoms or illness on the day of collection — fever, active infection, acute physiological stress; (3) smoking history; (4) corticosteroid use — type, dose, duration; (5) pregnancy status and gestational age — haemoglobin, haematocrit, and WBC reference ranges differ in pregnancy. Inspect the specimen for visible clotting before dispatch — a clotted EDTA specimen must be recollected. # REVIEWER FLAG: Confirm Access Medical Laboratories EDTA tube type (K2-EDTA vs K3-EDTA), required minimum fill volume, maximum acceptable transit time and temperature conditions, and whether a manual differential reflex protocol applies for flagged specimens.
Specimen requirements
Minimum 3.0 mL EDTA whole blood (standard 4.0 mL draw into a full-fill EDTA tube). Analyse or deliver within 6–8 hours at room temperature (18–25°C) for optimal WBC morphology and differential accuracy. Do not freeze. Do not refrigerate. # REVIEWER FLAG: Confirm minimum volume and maximum time-to-analysis with Access Medical Laboratories — confirm analyser platform (e.g. Sysmex, Beckman Coulter) as this affects extended parameters available.
What can affect CBC with Differential results?
The EDTA anticoagulant in the lavender-top tube must be thoroughly mixed with the blood specimen by 8–10 gentle inversions immediately after collection. Inadequate mixing allows microclot formation — small fibrin and platelet aggregates that trap platelets out of suspension, producing a spuriously low platelet count (pseudothrombocytopenia) that can trigger unnecessary platelet disorder investigation. This is the most common pre-analytical error in CBC specimen collection. Vigorous shaking must be avoided as it causes haemolysis, which interferes with multiple CBC parameters.
EDTA whole blood left unanalysed at room temperature undergoes progressive cellular deterioration — WBC morphology degrades within 4–6 hours (affecting differential accuracy), platelets swell artefactually elevating MPV, and erythrocytes undergo spherocytic shape change altering MCV and MCHC. Specimens should be analysed or in transit to the laboratory within 6–8 hours of collection at room temperature. Refrigeration of EDTA whole blood is not appropriate for CBC — cold causes platelet clumping and cold agglutination affecting the differential and RBC indices.
Catecholamine release from acute physical exercise, emotional distress, pain, fear, or acute illness mobilises the marginated neutrophil pool from vascular endothelial surfaces into the circulating pool within minutes, producing a transient neutrophilia and leucocytosis — physiological demargination — that resolves within hours of the stressor abating. A leucocytosis or neutrophilia identified on a CBC drawn immediately after vigorous exercise, an acutely stressful procedure, or during acute pain should not be attributed to infection or bone marrow pathology without clinical correlation and, where relevant, a repeat specimen under resting conditions.
Chronic cigarette smoking produces persistent leucocytosis — predominantly neutrophilia — through sustained airway inflammation and increased bone marrow myeloid output, with smokers averaging 1–2 ×10³/µL higher WBC than age-matched non-smokers. Smoking also stimulates erythropoietin production through relative tissue hypoxia, raising haemoglobin and haematocrit — a secondary erythrocytosis that must be distinguished from primary polycythaemia vera. Smoking history (pack-years) should be documented on the requisition form when interpreting both the white cell and red cell compartments.
Systemic glucocorticoids produce the 'steroid differential' — a characteristic and recognisable CBC pattern of neutrophilia (demargination and reduced apoptosis), lymphopenia (redistribution to lymphoid tissue), eosinopenia (sequestration), and monocytopenia. This pattern should not be misattributed to bacterial infection-driven leucocytosis when glucocorticoid use is documented. It resolves within 24–48 hours of corticosteroid discontinuation. High-dose corticosteroids can also mask fever and clinical signs of infection, making the CBC differential the primary remaining objective indicator of infectious process.
Approximately 0.1–0.2% of the population have naturally occurring EDTA-dependent antibodies that cause platelet aggregation in EDTA-anticoagulated blood ex vivo — a phenomenon unrelated to in vivo platelet function or thrombocytopenia. These individuals consistently produce spuriously low EDTA platelet counts despite having normal circulating platelets. When platelet count is unexpectedly low without clinical bleeding evidence and the patient appears well, EDTA pseudothrombocytopenia should be excluded by recollection into a citrate or heparin tube and manual film review before thrombocytopenia investigation is initiated.
What do CBC with Differential results mean?
Elevated
Leucocytosis (WBC >10.5 ×10³/µL) requires differential pattern interpretation: predominant neutrophilia suggests acute bacterial infection, physiological stress response, or corticosteroid effect; lymphocytosis with reactive forms suggests viral infection (EBV, CMV) or, in older patients, CLL; eosinophilia (>0.5 ×10³/µL) prompts evaluation for atopy, parasitic infection, drug reaction, or eosinophilic organ disorder; monocytosis (>1.0 ×10³/µL) suggests chronic infection, inflammatory disease, or monocytic leukaemia. Erythrocytosis (Hgb or Hct above the sex-specific upper limit) requires assessment for secondary causes — smoking, altitude, sleep apnoea, EPO-secreting tumour — before considering primary polycythaemia vera. Thrombocytosis (>400 ×10³/µL) is most commonly reactive — from iron deficiency, infection, or post-splenectomy — with essential thrombocythaemia a consideration when count persistently exceeds 600–800 ×10³/µL without reactive cause.
Normal
A fully normal CBC with differential in a symptomatic patient provides robust reassurance that common haematological contributions to the presenting complaint — anaemia, infectious leucocytosis, thrombocytopenia — are absent at the time of testing. A normal CBC does not exclude early haematological malignancy (early MDS, early lymphoma with normal peripheral blood), inherited haemolytic conditions with compensated haemolysis, or functional iron or nutritional deficiency before they have produced morphological haematological changes — clinical assessment and targeted second-tier investigation remain appropriate when pre-test clinical probability is high despite a normal CBC.
Reduced
Anaemia (Hgb below sex-specific lower limit) — classify by MCV and proceed to directed investigation. Neutropenia (ANC <1.8 ×10³/µL) requires urgency stratification: ANC <1.0 ×10³/µL warrants same-day clinical assessment; ANC <0.5 ×10³/µL is severe neutropenia requiring urgent specialist review. Causes include viral infection, drug toxicity, autoimmune neutropenia, and haematological malignancy. Thrombocytopenia (<150 ×10³/µL) — assess bleeding risk by count and clinical context: below 50 ×10³/µL carries significant spontaneous bleeding risk; below 20 ×10³/µL is a haematological emergency requiring same-day specialist review. Pancytopenia (simultaneous depression of WBC, Hgb, and platelets) mandates bone marrow assessment to exclude aplastic anaemia and haematological malignancy. In every case, confirm pseudocytopenia — EDTA-dependent platelet clumping, haemolysis causing cell fragmentation — before initiating investigation.
Note: The CBC is an automated analyser output that identifies quantitative abnormalities and applies morphological flags — it cannot replace peripheral blood film microscopy for definitive cell morphology assessment. When the analyser flags abnormal populations — blasts, atypical lymphocytes, giant platelets, fragmented erythrocytes (schistocytes), or NRBC — manual microscopic review by a trained morphologist is required before clinical decisions are based on the result. The MCHC is the most analytically sensitive index for haemolysis (spuriously elevated MCHC above 36 g/dL indicates haemolysis in the specimen) and for sickle cell disease assessment. The automated differential cannot reliably distinguish reactive lymphocytosis from early lymphoid malignancy — flow cytometry or manual review is required for this distinction. Pseudothrombocytopenia from EDTA-dependent platelet clumping is the most common cause of a single isolated low platelet count in an otherwise well patient — always verify with a film or alternative anticoagulant before thrombocytopenia investigation.
Frequently asked questions
The CBC with differential measures three blood cell lineages simultaneously: white blood cells — total count plus the proportional and absolute breakdown of neutrophils, lymphocytes, monocytes, eosinophils, and basophils; red blood cells — count, haemoglobin, haematocrit, and indices (MCV, MCH, MCHC, RDW) characterising erythrocyte size, haemoglobin content, and size distribution; and platelets with mean platelet volume. Together these parameters screen for anaemia and classify its type, characterise immune and inflammatory responses, identify infection patterns, and assess haemostatic capacity.
How to access the CBC with Differential test
The CBC with Differential reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: May 24, 2026
Last reviewed: May 24, 2026
- Bain BJ. Blood cells: a practical guide. 5th ed. Wiley-Blackwell. (2015)
- Lippi G, et al. Preanalytical variability in laboratory testing: current issues and future perspectives. Ann Transl Med. (2017)
- Bhat T, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. (2013)
- Lippi G, et al. Red blood cell distribution width: a key laboratory test for the prediction of morbidity and mortality in hospitalized patients. Clin Chim Acta. (2014)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
comprehensive panels
Anaemia Panel
The Anaemia Panel combines CBC with differential and erythrocyte indices (whole blood), iron studies — serum iron, TIBC, transferrin saturation, and ferritin (serum), reticulocyte count with production index (whole blood), and vitamin B12 and folate (serum) into a single coordinated multi-specimen panel, providing the complete diagnostic framework for anaemia characterisation across iron…
vitamins minerals
Ferritin
The Ferritin test measures serum ferritin, the circulating form of the body's principal iron-storage protein, as the standard indirect measure of total body iron stores. A low ferritin is the most specific routine marker of iron deficiency, while a high ferritin indicates iron overload or, commonly, an acute-phase inflammatory response.
metabolic diabetes
CMP
The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.